Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (40,854,855)	$ (16,918,477)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	5,196,156	4,074,458
Issuance of shares in licensing agreement	4,999,988	0
Stock-based 401K company common match	0	35,747
Amortization of debt discount	183,914	0
Depreciation expense	86	5,357
Operating lease expense	241,029	241,031
Finance lease amortization expense	48,992	0
Changes in operating assets and liabilities:
Prepaid expenses and other assets	(1,062,661)	(99,904)
Finance lease right-to-use asset	(423,880)	0
Accounts payable	(90,116)	(105,821)
Accrued expenses	6,126,004	452,382
Finance lease liabilities	220,625	0
Operating lease liabilities	(294,988)	(170,839)
Net cash used in operating activities	(25,709,706)	(12,486,066)
Cash flows from financing activities:
Proceeds from issuance of note payable	25,000,000	0
Payment for debt issuance costs	(449,329)	0
Proceeds from exercise of stock options	151,416	344,125
Payment of taxes in equity transaction	(270,959)	0
Proceeds from issuances of common stock, net of issuance costs	9,856,116	48,544,998
Net cash provided by financing activities	34,287,244	48,889,123
Net increase in cash and cash equivalents	8,577,538	36,403,057
Cash and cash equivalents at beginning of period	65,242,622	28,839,565
Cash and cash equivalents at end of period	73,820,160	65,242,622
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	852,221	0
Fair value of warrants issued in connection with debt	$ 1,713,741	$ 0